Rebecca Cook
Faculty Member
Last active: 4/15/2019

Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.

Walsh AJ, Cook RS, Manning HC, Hicks DJ, Lafontant A, Arteaga CL, Skala MC
Cancer Res. 2013 73 (20): 6164-74

PMID: 24130112 · PMCID: PMC3801432 · DOI:10.1158/0008-5472.CAN-13-0527

MeSH Terms (17)

Animals Antibodies, Monoclonal, Humanized Antineoplastic Agents Breast Neoplasms Cell Line, Tumor Disease Models, Animal Female Flavin-Adenine Dinucleotide Glycolysis Humans Mice Mice, Nude NAD Optical Imaging Receptor, ErbB-2 Trastuzumab Xenograft Model Antitumor Assays

Connections (5)

This publication is referenced by other Labnodes entities:

Links